Immunotherapy Approaches for Urothelial Bladder Cancer: Expert Guidance Through Challenging Cases Exploring the Fundamental Changes in Patient Care

Review these downloadable slides to gain expert perspective for optimal use of immune checkpoint inhibitors for patients with advanced bladder cancer. Faculty members Andrea Apolo, MD; Jean Hoffman-Censits, MD; Matthew I. Milowsky, MD; and Elizabeth R. Plimack, MD, MS, explain the current clinical rational and use of these immunotherapy options. Click here to use our online tool to see how to select optimal therapy for your patients.

Downloadable Slidesets

In this downloadable slideset, Elizabeth R. Plimack, MD, MS, discusses the mechanism of action and clinical rationale for the use of immune checkpoint inhibitors in patients with bladder cancer.

Released: February 12, 2018

In this downloadable slideset, Matthew I. Milowsky, MD, discusses the current neoadjuvant and adjuvant treatment landscape in bladder cancer and highlights ongoing trials with immune checkpoint inhibitors in this setting.

Released: February 13, 2018

In this downloadable slideset, Jean Hoffman-Censits, MD, discusses the optimal use of immune checkpoint inhibitors for patients with treatment-naïve advanced bladder cancer.

Released: February 14, 2018

In this downloadable slideset, Elizabeth R. Plimack, MD, MS, discusses the data on recent approvals for immune checkpoint inhibitors for patients with advanced bladder cancer who have progressed on previous therapy.

Released: February 14, 2018

In this downloadable slideset, Andrea B. Apolo, MD, addresses the management of adverse events associated with immune checkpoint inhibitors and highlights new data for treatment options after immune checkpoint inhibitors for optimal outcomes in patients with advanced bladder cancer.

Released: February 14, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Produced in collaboration with
Educational grant provided by:
Merck & Co., Inc.
Seattle Genetics
Astellas

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?